BlackRock’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $861M | Sell |
3,798,560
-60,540
| -2% | -$10.8M | 0.01% | 852 |
|
|
2026
Q1 | $666M | Buy |
3,859,100
+104,746
| +3% | +$19.4M | 0.01% | 912 |
|
|
2025
Q4 | $749M | Sell |
3,754,354
-101,712
| -3% | -$18.4M | 0.01% | 838 |
|
|
2025
Q3 | $603M | Buy |
3,856,066
+199,934
| +5% | +$31.8M | 0.01% | 964 |
|
|
2025
Q2 | $555M | Sell |
3,656,132
-14,693
| -0.4% | -$1.96M | 0.01% | 990 |
|
|
2025
Q1 | $553M | Sell |
3,670,825
-561,345
| -13% | -$94.1M | 0.01% | 969 |
|
|
2024
Q4 | $781M | Sell |
4,232,170
-6,166
| -0.1% | -$1.19M | 0.02% | 780 |
|
|
2024
Q3 | $835M | Sell |
4,238,336
-849,681
| -17% | -$177M | 0.02% | 733 |
|
|
2024
Q2 | $1.05B | Sell |
5,088,017
-83,767
| -2% | -$19M | 0.02% | 567 |
|
|
2024
Q1 | $1.4B | Buy |
5,171,784
+10,424
| +0.2% | +$2.49M | 0.03% | 473 |
|
|
2023
Q4 | $1.22B | Buy |
5,161,360
+40,793
| +0.8% | +$8.02M | 0.03% | 504 |
|
|
2023
Q3 | $1B | Sell |
5,120,567
-77,470
| -1% | -$15.9M | 0.03% | 528 |
|
|
2023
Q2 | $1.09B | Buy |
5,198,037
+411,153
| +9% | +$81.8M | 0.03% | 510 |
|
|
2023
Q1 | $966M | Sell |
4,786,884
-171,343
| -3% | -$38.8M | 0.03% | 548 |
|
|
2022
Q4 | $1.08B | Sell |
4,958,227
-350,971
| -7% | -$76.6M | 0.03% | 487 |
|
|
2022
Q3 | $1.04B | Sell |
5,309,198
-17,014
| -0.3% | -$3.67M | 0.04% | 472 |
|
|
2022
Q2 | $1.14B | Buy |
5,326,212
+96,179
| +2% | +$23.5M | 0.04% | 467 |
|
|
2022
Q1 | $1.49B | Buy |
5,230,033
+150,007
| +3% | +$46.3M | 0.04% | 443 |
|
|
2021
Q4 | $1.91B | Sell |
5,080,026
-7,667
| -0.2% | -$2.98M | 0.05% | 375 |
|
|
2021
Q3 | $2.1B | Buy |
5,087,693
+152,682
| +3% | +$63.4M | 0.06% | 321 |
|
|
2021
Q2 | $1.83B | Sell |
4,935,011
-656,200
| -12% | -$219M | 0.05% | 363 |
|
|
2021
Q1 | $1.62B | Buy |
5,591,211
+221,598
| +4% | +$61.6M | 0.05% | 389 |
|
|
2020
Q4 | $1.34B | Buy |
5,369,613
+20,073
| +0.4% | +$4.78M | 0.04% | 424 |
|
|
2020
Q3 | $1.21B | Buy |
5,349,540
+8,157
| +0.2% | +$1.69M | 0.04% | 393 |
|
|
2020
Q2 | $931M | Buy |
5,341,383
+877,241
| +20% | +$140M | 0.04% | 455 |
|
|
2020
Q1 | $563M | Sell |
4,464,142
-29,811
| -0.7% | -$4.47M | 0.03% | 557 |
|
|
2019
Q4 | $686M | Sell |
4,493,953
-114,797
| -2% | -$15.9M | 0.03% | 627 |
|
|
2019
Q3 | $610M | Sell |
4,608,750
-51,878
| -1% | -$6.96M | 0.03% | 630 |
|
|
2019
Q2 | $661M | Buy |
4,660,628
+72,827
| +2% | +$9.88M | 0.03% | 603 |
|
|
2019
Q1 | $666M | Buy |
4,587,801
+57,789
| +1% | +$7.59M | 0.03% | 587 |
|
|
2018
Q4 | $513M | Buy |
4,530,012
+18,491
| +0.4% | +$2.32M | 0.03% | 642 |
|
|
2018
Q3 | $607M | Buy |
4,511,521
+64,556
| +1% | +$7.97M | 0.03% | 647 |
|
|
2018
Q2 | $499M | Buy |
4,446,965
+292,685
| +7% | +$31.6M | 0.02% | 733 |
|
|
2018
Q1 | $443M | Buy |
4,154,280
+119,962
| +3% | +$12.9M | 0.02% | 783 |
|
|
2017
Q4 | $442M | Buy |
4,034,318
+31,676
| +0.8% | +$3.45M | 0.02% | 785 |
|
|
2017
Q3 | $432M | Sell |
4,002,642
-20,240
| -0.5% | -$2.08M | 0.02% | 755 |
|
|
2017
Q2 | $407M | Buy |
4,022,882
+177,239
| +5% | +$16.3M | 0.02% | 762 |
|
|
2017
Q1 | $346M | Buy |
3,845,643
+3,815,298
| +12,573% | +$324M | 0.02% | 867 |
|
|
2016
Q4 | $2.31M | Buy |
30,345
+123
| +0.4% | +$9.34K | ﹤0.01% | 1174 |
|
|
2016
Q3 | $2.52M | Sell |
30,222
-15,331
| -34% | -$1.29M | ﹤0.01% | 1118 |
|
|
2016
Q2 | $3.76M | Buy |
45,553
+14,455
| +46% | +$1.19M | 0.01% | 946 |
|
|
2016
Q1 | $2.36M | Sell |
31,098
-71,645
| -70% | -$5.3M | ﹤0.01% | 1061 |
|
|
2015
Q4 | $8.26M | Sell |
102,743
-38,251
| -27% | -$2.76M | 0.01% | 726 |
|
|
2015
Q3 | $8.96M | Buy |
140,994
+300
| +0.2% | +$21.5K | 0.01% | 654 |
|
|
2015
Q2 | $9.9M | Sell |
140,694
-38,771
| -22% | -$2.87M | 0.01% | 669 |
|
|
2015
Q1 | $14.2M | Buy |
179,465
+24,320
| +16% | +$1.79M | 0.02% | 606 |
|
|
2014
Q4 | $9.87M | Sell |
155,145
-120,094
| -44% | -$7.53M | 0.01% | 677 |
|
|
2014
Q3 | $16.4M | Sell |
275,239
-15,546
| -5% | -$889K | 0.02% | 567 |
|
|
2014
Q2 | $15.6M | Sell |
290,785
-193,569
| -40% | -$10.6M | 0.02% | 574 |
|
|
2014
Q1 | $29.2M | Buy |
484,354
+478,332
| +7,943% | +$27.9M | 0.05% | 408 |
|
|
2013
Q4 | $319K | Buy |
6,022
+1
| +0% | +$50 | ﹤0.01% | 1479 |
|
|
2013
Q3 | $278K | Hold |
6,021
| – | – | ﹤0.01% | 1415 |
|
|
2013
Q2 | $247K | Buy |
+6,021
| New | +$258K | ﹤0.01% | 1443 |
|
Other funds holding CRL
AI
BlackRock's CRL Position: Q2 2026 in Review
BlackRock reduced its Charles River Laboratories (CRL) stake by 1.6% in Q2 2026, selling an estimated $10.8M and leaving 3,798,560 shares worth $861M. The position accounts for 0.01% of the portfolio, ranked #852.
BlackRock first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.1B in Q3 2021. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- BlackRock held 3,798,560 shares of Charles River Laboratories worth $861M as of Q2 2026.
- BlackRock sold 60,540 Charles River Laboratories shares in Q2 2026, an estimated $10.8M.
- Charles River Laboratories made up 0.01% of BlackRock's portfolio in Q2 2026, its #852 holding.
- BlackRock first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
- BlackRock's Charles River Laboratories position peaked at $2.1B in Q3 2021.
- 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.